Germany needs nine months to ban a synthetic drug; online shops need only a new molecule

German law tries to control new synthetic drugs by prohibiting chemical families rather than waiting to name every molecule. Online sellers have adapted. They alter substances just beyond the covered group or sell a legal precursor that the body’s enzymes convert into an already prohibited drug. Shops present the compounds as research materials and can replace a banned product almost immediately.

CORRECTIV follows one family’s experience with that system. Christian—an anonymised name—ordered stimulants and benzodiazepine derivatives from a conventional-looking website. Two substances he bought, 3,4-EtMC HCL and Noravizafone, were added to expanded prohibited groups in April 2026. The shop announced their removal and promised chemically similar replacements. Christian died after a relapse; the investigation cannot establish whether the drugs caused his death because no determination was made.

That uncertainty is structural. German states collect drug-death data differently, and only a small share of deaths receive toxicological examination. Some police agencies do not separate research chemicals from broad opioid categories. Investigators may therefore know that a fast-changing market exists without being able to measure its mortality, identify suppliers or see which compound is spreading until hospitals and users begin reporting harm.

Germany has a national early-warning team that monitors toxicology, forums and online shops. Yet adding a newly detected substance to the rules takes at least nine months, according to a Bavarian criminal-police chemist. The team had been tracking PHM, an opioid described as at least ten times as potent as morphine, when it received notice of a death in Baden-Württemberg.

This is an enforcement problem in which the regulated object changes faster than the rule. Broader chemical-family bans help but cannot fully contain prodrugs or unknown analogues. A more effective response needs faster temporary scheduling, routine and comparable toxicology, rapid warnings to treatment services, and scrutiny of the retail and payment infrastructure that lets a dangerous experiment look like ordinary ecommerce.